ClinicalTrials.gg
Status unknownNCT05558930CTPDOCUpdated Sep 28, 2022

Cerebellar iTBS in Patients With Disorders of Consciousness

An interventional study of iTBS stimulation and sham stimulation in Disorder of Consciousness, Vegetative State and Minimally Conscious State, sponsored by Xijing Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-28.

Sponsored by Xijing Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2022, registered Sep 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex.Investigator evaluate the effects of bilateral cerebellar TMS on Coma Recovery Scale-Revised (CRS-R) scores in patients with disorders of consciousness(DOC) in a randomized, double-blinded, sham-controlled, crossover experimental design.

Read the detailed description

Patients with disorders of consciousness(DOC) resulting from severe brain injury greatly burden caregivers, health care facilities, and society. However, there is no definitively effective treatment for patients with DOC.

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex through the dentato-rubro-thalamic tract. Investigators aim to validate the effect of 5 consecutive sessions of intermittent theta-burst stimulation(iTBS) of bilateral cerebellar on level of consciousness of patients in vegetative state(VS)/unresponsive awakening state(UWS)or minimally conscious (MCS) state in a randomized, double-blinded, sham-controlled, crossover study.

TMS is a non-invasive and safe neural regulatory approach that is widely used in depression, schizophrenia, stroke, and Parkinson's disease.

02

Conditions studied

  • Disorder of Consciousness
  • Vegetative State
  • Minimally Conscious State

Keywords

  • TMS
  • cerebellar
  • iTBS
  • DOC
  • MCS
  • VS
03

In context

Consciousness Disorders

290 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

This study's planned enrollment of 44 is close to the median of 47 across 191 interventional studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

Xijing Hospital is the lead sponsor of 474 studies on the registry; 159 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. VS/UWS or MCS according to diagnostic criteria
  2. Age ≥18 years
  3. Written obtained

Exclusion criteria

Exclusion Criteria:

  1. Patients in coma
  2. Brain injury \<1week
  3. Presence of metallic hardware in close contact to the discharging coil(such as cochlear implants, or an Internal Pulse Generator or medication pumps)
  4. Patients with high risks according to standard questionnaire to screen transcranial magnetic stimulation(TMS) candidates
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    iTBS stimulation

    Participants receive iTBS stimulation of bilateral cerebellar one session per day for 5 consecutive days.

    Device: iTBS stimulation

  • Sham comparator
    sham stimulation

    Participants receive sham stimulation of bilateral cerebellar one session per day for 5 consecutive days.

    Device: sham stimulation

Interventions

  • DeviceiTBS stimulation

    standard iTBS burst pattern:3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals. 600 pulses on both side of cerebellar with an interval of 5 minutes.

  • Devicesham stimulation

    Participants receive a sound stimulation with the same pattern with iTBS stimulation,but without magnetic field

06

What researchers measure

Primary outcomes

  1. Change in CRS-R Total Scores

    Whether bilateral cerebellar iTBS would improve consciousness in enrolled patients. CRS-R total score is used to measure level of consciousness of disorder.The coma recovery scale-revised(CRS-R) consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. Maximum scores of each subscale are summed to obtain the total score (from 0 to 23).The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

    Time frame: Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

Secondary outcomes

  1. Change in CRS-R Subscale Scores

    The coma recovery scale-revised(CRS-R) consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

    Time frame: Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

  2. Change of Influence on EEG

    EEG will be monitored on the first and fifth sessions of both iTBS and sham stimulation, from 20 minutes before the start of stimulation until 30 minutes after the end of stimulation.

    Time frame: Baseline and after 5 sessions of iTBS and sham stimulation(5 days)

  3. Influence of time since insult on the results

    Glasgow Outcome Scale-Extended(GOSE) score will be assessed at 3 and 6 months of enrollment.

    Time frame: Participants will be followed for the duration of 0.5 year

07

Study locations

1 of 1 sites recruiting
  • Xijing hospital, Air Force Military Medical University
    Xi'an, Shaanxi 710032, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05558930
Lead sponsor
Xijing Hospital
Responsible party
Sponsor
First posted
Sep 28, 2022
Start date
Apr 29, 2022
Primary completion
Apr 2023 (estimated)
Completion
Oct 2023 (estimated)
Last update
Sep 28, 2022

Study contacts

Rong Chen
Contact
cmuchenrong@126.com
18292575563
Wen Jiang
Contact

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion